Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+135.1%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
+135.1%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
13x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2021 | 99.91% |
| Q3 2021 | 8.62% |
| Q2 2021 | 3.33% |
| Q1 2021 | -11.11% |
| Q4 2020 | 16.92% |
| Q3 2020 | -10.17% |
| Q2 2020 | 7.81% |
| Q1 2020 | 1.54% |
| Q4 2019 | 12.16% |
| Q3 2019 | 10.84% |
| Q2 2019 | -22.06% |
| Q1 2019 | 5.56% |
| Q4 2018 | 7.69% |
| Q3 2018 | -41.82% |
| Q2 2018 | -14.58% |
| Q1 2018 | -6.67% |
| Q4 2017 | 0.00% |